Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0016053 (
fibromyalgia
)
4,687
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the broader list of cognitive concerns, neuropsychological testing has shown that attentional impairment may have a specific burden in
Fibromyalgia Syndrome
(
FMS
). Preliminary observations have reported a subset of
FMS
patient screened for attention disorders fulfilling the actual diagnosis of ADHD, a neurodevelopmental disorder characterized by developmentally inadequate levels of inattention, hyperactivity and impulsivity that might persist in adulthood. Yet, no study to date has systematically examined the history and the specific contribution of ADHD to
FMS
in terms of clinical impact and related specific disabilities. In this study, 106 individuals with a
FMS
diagnosis based on the 2010 criteria of the American College of Rheumatology have been assessed for (a) the presence of ADHD; (b) the burden of disability caused by ADHD versus
FMS
; (c) the presence of other psychiatric disorders. Results indicated that ADHD was present in 24.5% of
FMS
individuals, it was associated with higher
FMS
symptoms severity and a greater functional impairment, particularly in the work/school domain. Moreover, patients with both
FMS
and ADHD had higher frequency of
substance use disorders
than those with
FMS
only (38.5% versus 3.8%) and mainly opioids. Overall, results suggest that ADHD can increase burden adding specific disability in work and social activities, and it is associated with a trend for the excessive use of opioid painkillers. Detection of neurodevelopmental and actual symptoms of ADHD is highly recommended especially in patient prone to increase the dose of anti-pain medication.
...
PMID:Adult attention deficit hyperactivity disorder in patients with fibromyalgia syndrome: Assessment and disabilities. 3312 72